Examination Report |
1 | Additional Representation Sheet | 08 May 2009 |
1 | Cover To Cover | 08 May 2009 |
10 | Letters related to TOP | 17 Apr 2015 |
11 | TM-16 | 08 Feb 2017 |
12 | Correspondence | 09 Aug 2017 |
13 | Correspondence | 14 Aug 2017 |
14 | Letters related to TOP | 09 Oct 2017 |
15 | Letters related to TOP | 02 May 2019 |
16 | Letters related to TOP | 17 Sep 2019 |
17 | Letters related to TOP | 13 Jan 2020 |
18 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 13 Apr 2020 |
19 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 14 Jul 2020 |
2 | Cover To Cover | 08 May 2009 |
2 | TM-1 | 08 May 2009 |
20 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 13 Jan 2021 |
21 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 13 Jan 2021 |
22 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 10 Sep 2021 |
23 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 10 Sep 2021 |
24 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 01 Apr 2022 |
25 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 12 Apr 2022 |
26 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 21 Apr 2022 |
27 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 25 Apr 2022 |
28 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 07 Oct 2022 |
29 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 03 Dec 2022 |
3 | Additional Representation Sheet | 08 May 2009 |
3 | TM-1 | 08 May 2009 |
30 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 29 Dec 2022 |
31 | Order | 03 Jan 2023 |
32 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 12 Apr 2023 |
33 | Annexure -1 under rule 46 | 11 Sep 2023 |
33 | Evidence Affidavit Under Rule 46 (TOP) | 11 Sep 2023 |
34 | Annexure -1 under rule 46 | 11 Sep 2023 |
34 | Evidence Affidavit Under Rule 46 (TOP) | 11 Sep 2023 |
35 | Annexure -1 under rule 46 | 11 Sep 2023 |
35 | Evidence Affidavit Under Rule 46 (TOP) | 11 Sep 2023 |
36 | Annexure -1 under rule 46 | 11 Sep 2023 |
36 | Evidence Affidavit Under Rule 46 (TOP) | 11 Sep 2023 |
37 | Annexure -1 under rule 46 | 11 Sep 2023 |
37 | Evidence Affidavit Under Rule 46 (TOP) | 11 Sep 2023 |
38 | Annexure -1 under rule 46 | 11 Sep 2023 |
38 | Evidence Affidavit Under Rule 46 (TOP) | 11 Sep 2023 |
39 | Annexure -1 under rule 46 | 11 Sep 2023 |
39 | Evidence Affidavit Under Rule 46 (TOP) | 11 Sep 2023 |
4 | Reply to Exam Report (MIS-R) | 09 Jun 2012 |
40 | Evidence Affidavit Under Rule 46 (TOP) | 11 Sep 2023 |
41 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 12 Dec 2023 |
42 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 01 Jan 2024 |
43 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 02 Jul 2024 |
44 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 02 Jul 2024 |
45 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 17 Dec 2024 |
46 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 17 Dec 2024 |
5 | Order | 07 Sep 2012 |
6 | TM-44 | 31 Dec 2012 |
7 | TM-5 | 31 Dec 2012 |
8 | TM-5 | 10 Jan 2013 |
9 | TM-16 | 29 Jan 2013 |
1 | Opposition Counter Statement | 4741240 | 03 May 2017 | |
2 | Hearing Notice | 14356140 | 5768206 | 17 Nov 2022 |
3 | Opposition Counter Statement | 14629163 | 5825687 | 12 Jan 2023 |
The application for Supra was made on 08 May 2009.
The trademark applicant for Supra is ABBOTT HEALTHCARE.
Supra is applied in class(es) 5.
Application for Supra is on Opposed stage.
Application Id allotted to Supra is 1816083.
Trademark agent or attorney for the application is Zeusip.
Supra filed with the Intellectual property office as a WORD.